Chinopyrin is a medical term used to describe a substance that can reduce inflammation and fever. The spelling of this word can be a bit tricky, as it contains a combination of letters that are not commonly used in English. The IPA phonetic transcription for chinopyrin is /tʃɪˈnɔpɪrɪn/. This means that the first syllable is pronounced with a "ch" sound, followed by a short "i" sound. The last syllable is pronounced with a short "i" sound, followed by a nasal "n" sound and ending with the "rin" sound.
Chinopyrin is a chemical compound, specifically a synthetic pyridine derivative, that is predominantly used as a precursor and intermediate in the synthesis of various pharmaceutical drugs. It belongs to the class of antipyretic and analgesic agents, which are substances used to reduce fever and relieve pain, respectively.
As a medicinal compound, chinopyrin exhibits its pharmacological effects by acting on certain receptors and enzymes in the body. It is known to possess anti-inflammatory properties, making it useful in treating conditions characterized by inflammation, such as rheumatoid arthritis. Additionally, chinopyrin has also shown potential in inhibiting the production of certain pain-inducing substances in the body, thereby providing relief from mild to moderate pain.
The chemical structure of chinopyrin consists of a pyridine ring, which is a six-membered aromatic ring containing five carbon atoms and one nitrogen atom. This structural feature gives chinopyrin its characteristic properties and allows it to interact with specific molecular targets within the body.
It is worth noting that chinopyrin is a synthetic compound and is not found naturally in any plant or animal sources. Due to its pharmaceutical importance, chinopyrin is produced through chemical synthesis in laboratories. However, its usage and availability may be subject to regulatory controls and prescriptions, depending on the jurisdiction and intended purpose.
Quinopyrine.
A practical medical dictionary. By Stedman, Thomas Lathrop. Published 1920.